PRO MEDICUS News & Analysis

This week’s Investing Compass episode goes through what we can learn from top performing stocks. 

Applying lessons from a recent examination of Pro Medicus to explore the chances of another ASX share turning into the next multi-bagger.  

Market exuberance surrounds Pro Medicus with a surging share price but does the valuation match its fundamentals?

A well-known supermarket retailer and a New Zealand software giant are among Morningstar's most overvalued ASX stocks.

Materials and health stocks are among the most overvalued ASX companies under Morningstar coverage. We identify 5 to avoid at current prices.

Mid-cap stocks have been underperforming large companies on the ASX because of the greater volatility, but asset managers expect this pattern to...